Featured Publication Keeping The Promise Click here to download the full reportResearch Papers Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis Assessment of the Carcinogenic Potential of Pretomanid in Transgenic Tg.rasH2 MiceFor the PressPress Contact:Thomas Lynchp | +1 646 616 8639e | thomas.lynch@tballiance.org View the 2021 Annual Report
